authors
- Welch, S
- Hirte, H
- Schilder, RJ
- Elit, Laurie
- Townsley, C
- Tinker, L
- Pond, Gregory
- Afinec, A
- Wright, JJ
- Oza, AM
Phase II study of sorafenib (BAY 43-9006) in combination with gemcitabine in recurrent epithelial ovarian cancer: A PMH phase II consortium trial.
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- June 20, 2006
has subject area
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Journal of Clinical Oncology Journal